British Columbia Cancer Agency: Neoplasm Metastasis trials

The registry lists 11 Neoplasm Metastasis studies with British Columbia Cancer Agency as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 2 1Phase 3 1No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• High Dose Radiotherapy for Palliation (Hi-D)Not yet recruitingNCT07291895Not applicable
• Stereotactic Radiotherapy Versus Palliative Conventional Radiotherapy for Oligoprogressive Metastatic CancersRecruitingNCT06918951Not applicable
• Diagnostic CT Palliative Radiotherapy: Feasibility Study of Treating Bone Metastases Without a CT SimulationNot yet recruitingNCT06235034Not applicable
• Personalized Oncogenomics (POG) Program of British ColumbiaRecruitingNCT02155621Not applicable
• Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) CancerActive, not recruitingNCT03862911Not applicable
• Study of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLCActive, not recruitingNCT03769103Phase 2
• SUPR-3D: Simple Unplanned Palliative Radiotherapy Versus 3D Conformal Radiotherapy for Patients With Bone MetastasesTerminatedNCT03694015Not applicable
• Stereotactic Ablative Body Radiotherapy (SABR) for OligometastasesActive, not recruitingNCT02933242Not applicable
• Whole Brain Radiotherapy Versus Volumetric Modulated Arc Therapy for Brain MetastasesCompletedNCT02220491Not applicable
• 18F-NaF PET Imaging for Bone ScintigraphyCompletedNCT01930812Phase 3
• Volumetric Modulated Arc Therapy (VMAT) for Brain MetastasesActive, not recruitingNCT01046123Not applicable